Yayın:
Pars plana vitrectomy and removal of the internal limiting membrane in the treatment of chronic macular oedema

dc.contributor.buuauthorAvcı, Remzi
dc.contributor.buuauthorKaderli, Berkant
dc.contributor.buuauthorAvcı, Berrin
dc.contributor.buuauthorŞimşek, Şaban A.
dc.contributor.buuauthorBaykara, Mehmet
dc.contributor.buuauthorKahveci, Zeynep
dc.contributor.buuauthorGelişken, Öner
dc.contributor.buuauthorYücel, Ahmet Ali
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentGöz Hastalıkları Ana Bilim Dalı
dc.contributor.researcheridABE-6685-2020
dc.contributor.scopusid7004838001
dc.contributor.scopusid6507602756
dc.contributor.scopusid6603017388
dc.contributor.scopusid35557651300
dc.contributor.scopusid6602526353
dc.contributor.scopusid7005217049
dc.contributor.scopusid23093006700
dc.contributor.scopusid6603395784
dc.date.accessioned2021-09-14T13:20:31Z
dc.date.available2021-09-14T13:20:31Z
dc.date.issued2004-10
dc.description.abstractBackground: To evaluate the results of pars plana vitrectomy with peeling of the internal limiting membrane (ILM) in eyes with chronic macular oedema. Methods: PPV with indocyanine green (ICG) assisted peeling of the ILM was performed in 33 eyes with diabetic (21 eyes) or,non-diabetic (12 eyes) macular oedema. Postoperatively, resolution of macular oedema, improvement of visual acuity (VA) and complications were documented. The peeled membranes were submitted for light and transmission electron microscopic evaluation. Results: The mean follow-up time was 12.2 months. The macular oedema decreased or was resolved in 17 (81%) eyes in the diabetic group and in 11 (92%) eyes in the non-diabetic group. VA improved by at least 2 lines in 11 (52%) eyes in the diabetic group and in 7 (58%) eyes in the non-diabetic group. The difference between visual acuity improvements of the two groups was not statistically significant (P>0.05). However, in the diabetic group the difference of visual improvement between cystoid and diffuse type of macular oedema eyes was statistically significant (14% versus 71%, P=0.02). Light and transmission electron microscopy showed the presence of ILM in all specimens. During the follow-up period no recurrence of macular oedema or epiretinal membrane formation was observed. Conclusion: Pars plana vitrectomy with peeling of the ILM and epiretinal membrane leads to the resolution of macular oedema in the majority of eyes. This however, is not always associated with VA improvement. In diabetic eyes, cystoid type of macular oedema appears to be a poor prognostic factor for improved VA.
dc.identifier.citationAvcı, R. vd. (2004). “Pars plana vitrectomy and removal of the internal limiting membrane in the treatment of chronic macular oedema”. Graefes Archive for Clinical and Experimental Ophthalmology, 242(10), 845-852.
dc.identifier.doi10.1007/s00417-004-0939-2
dc.identifier.endpage852
dc.identifier.issn0721-832X
dc.identifier.issue10
dc.identifier.pubmed15221309
dc.identifier.scopus2-s2.0-8444227790
dc.identifier.startpage845
dc.identifier.urihttps://doi.org/10.1007/s00417-004-0939-2
dc.identifier.urihttps://link.springer.com/article/10.1007%2Fs00417-004-0939-2
dc.identifier.urihttp://hdl.handle.net/11452/21957
dc.identifier.volume242
dc.identifier.wos000225104800006
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherSpringer
dc.relation.journalGraefes Archive for Clinical and Experimental Ophthalmology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectOphthalmology
dc.subjectVascular-permeability factor
dc.subjectRetinal vein occlusion
dc.subjectEndothelial growth-factor
dc.subjectIndocyanine-green
dc.subjectHole
dc.subjectSurgery
dc.subjectDamage
dc.subject.emtreeIndocyanine green
dc.subject.emtreeAdult
dc.subject.emtreeAged
dc.subject.emtreeCiliary disk
dc.subject.emtreeClinical article
dc.subject.emtreeClinical observation
dc.subject.emtreeControlled study
dc.subject.emtreeDiabetic retinopathy
dc.subject.emtreeDisease classification
dc.subject.emtreeEpiretinal membrane
dc.subject.emtreeFemale
dc.subject.emtreeFollow up
dc.subject.emtreeHistopathology
dc.subject.emtreeHuman
dc.subject.emtreeMale
dc.subject.emtreeMedical documentation
dc.subject.emtreeOutcomes research
dc.subject.emtreePostoperative complication
dc.subject.emtreePostoperative period
dc.subject.emtreePriority journal
dc.subject.emtreePrognosis
dc.subject.emtreeRecurrent disease
dc.subject.emtreeRetina macula cystoid edema
dc.subject.emtreeRetina macula edema
dc.subject.emtreeStatistical significance
dc.subject.emtreeSurgical approach
dc.subject.emtreeTransmission electron microscopy
dc.subject.emtreeTreatment planning
dc.subject.emtreeVisual acuity
dc.subject.emtreeVitrectomy
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshBasement membrane
dc.subject.meshChronic disease
dc.subject.meshColoring agents
dc.subject.meshDiabetic retinopathy
dc.subject.meshEpiretinal membrane
dc.subject.meshFemale
dc.subject.meshFluorescein angiography
dc.subject.meshHumans
dc.subject.meshIndocyanine green
dc.subject.meshMacular edema, cystoid
dc.subject.meshMale
dc.subject.meshMiddle aged
dc.subject.meshProspective studies
dc.subject.meshVisual acuity
dc.subject.meshVitrectomy
dc.subject.scopusMacular Edema; Ranibizumab; Laser Coagulation
dc.subject.wosOphthalmology
dc.titlePars plana vitrectomy and removal of the internal limiting membrane in the treatment of chronic macular oedema
dc.typeArticle
dc.wos.quartileQ2
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Göz Hastalıkları Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Dosyalar

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama